Tuscan Ridge Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-21,700
Closed -$1.13M 594
2018
Q4
$1.13M Buy
+21,700
New +$1.17M 0.11% 228

Other funds holding BMY

Tuscan Ridge Asset Management's BMY Position: Q2 2019 in Review

Tuscan Ridge Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 38,112 shares — an estimated $1.82M sold.

Tuscan Ridge Asset Management first reported a position in BMY in Q4 2018 and held it in 2 quarters. The position peaked at $2.96M in Q4 2018. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

  • Tuscan Ridge Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
  • Tuscan Ridge Asset Management sold 38,112 Bristol-Myers Squibb shares in Q2 2019, an estimated $1.82M.
  • Tuscan Ridge Asset Management first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 2 quarters.
  • Tuscan Ridge Asset Management's Bristol-Myers Squibb position peaked at $2.96M in Q4 2018.
  • 1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Tuscan Ridge Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.